Skip to main navigation

Mersana Therapeutics

Search

Main navigation

  • About
    • Mission & Vision
    • Executive Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partnering
  • Pipeline
    • Overview
    • XMT-1536
    • XMT-1592
  • Technology Platforms
    • About ADCs
    • DolaLock Tecknology
    • Dolaflexin
    • Dolasynthen
    • Immunosynthen
  • Publications
  • Investors & Media
    • Overview
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Press Releases
    • Events & Presentations
    • Annual Meeting
    • Corporate Governance
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Benefits
    • Open Positions
  • Contact

Events & Presentations

Events & Presentations

Featured Events
Mersana First Quarter 2022 Earnings Call
May 9, 2022 at 8:00 AM EDT
Listen to webcast
AACR-NCI-EORTC 2021 Conference - XMT-2056: Tumor-targeted Innate Immune Activation via a STING-agonist Antibody Drug Conjugate
October 7, 2021
Listen to webcast
View Presentation 1.9 MB
Presentations
May 2022 Corporate Presentation
Mersana UpRi Clinical Development Strategy and Interim Data from the Ovarian Cancer Expansion Cohort of the Phase I Study Presentation
Upcoming Events
There are currently no events to display.
Past Events
Mersana First Quarter 2022 Earnings Call
May 9, 2022 at 8:00 AM EDT
Listen to webcast
Cowen 42nd Annual Health Care Conference
March 9, 2022 at 12:50 PM EST
Listen to webcast
Mersana Fourth Quarter 2021 Earnings Call
February 28, 2022 at 8:00 AM EST
Listen to webcast

Toolkit

Email Alerts
Contact Us
RSS Feeds
© 2022 Mersana Therapeutics, All Rights Reserved. Privacy Policy | Terms of Use
Linkedin Twitter Facebook Instagram
logo

Main navigation

  • About
    • Mission & Vision
    • Executive Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partnering
  • Pipeline
    • Overview
    • XMT-1536
    • XMT-1592
  • Technology Platforms
    • About ADCs
    • DolaLock Tecknology
    • Dolaflexin
    • Dolasynthen
    • Immunosynthen
  • Publications
  • Investors & Media
    • Overview
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Press Releases
    • Events & Presentations
    • Annual Meeting
    • Corporate Governance
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Benefits
    • Open Positions
  • Contact